{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:09:52Z","timestamp":1759579792175},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2004,12,1]]},"DOI":"10.1038\/sj.bmt.1704717","type":"journal-article","created":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T11:52:40Z","timestamp":1099309960000},"page":"1039-1045","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies"],"prefix":"10.1038","volume":"34","author":[{"given":"E P","family":"Alessandrino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Bernasconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A A","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Caldera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Malcovati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Troletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Vanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Varettoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Lazzarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,11,1]]},"reference":[{"key":"BF1704717_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1056\/NEJM199403243301206","volume":"330","author":"JO Armitage","year":"1994","unstructured":"Armitage JO . Bone marrow transplantation. N Engl J Med 1994; 330: 827\u2013838.","journal-title":"N Engl J Med"},{"key":"BF1704717_CR2","first-page":"13","volume":"17","author":"F Frassoni","year":"1996","unstructured":"Frassoni F, Labopin M, Gluckman E et al. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time \u2013 a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Bone Marrow Transplant 1996; 17: 13\u201318.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704717_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.1993.03510010063030","volume":"270","author":"O Ringden","year":"1993","unstructured":"Ringden O, Horowitz MM, Gale RP et al. Outcome after allogeneic bone marrow transplant for leukemia in older adults. JAMA 1993; 270: 57\u201360.","journal-title":"JAMA"},{"key":"BF1704717_CR4","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","volume":"89","author":"S Giralt","year":"1997","unstructured":"Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997; 89: 4531\u20134536.","journal-title":"Blood"},{"key":"BF1704717_CR5","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1200\/JCO.1998.16.8.2817","volume":"16","author":"IF Khouri","year":"1998","unstructured":"Khouri IF, Keating M, Korbling M et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol 1998; 16: 2817\u20132824.","journal-title":"J Clin Oncol"},{"key":"BF1704717_CR6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756\u2013763.","journal-title":"Blood"},{"key":"BF1704717_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1084\/jem.169.2.493","volume":"169","author":"Y Sharabi","year":"1989","unstructured":"Sharabi Y, Sachs DH . Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989; 169: 493\u2013502.","journal-title":"J Exp Med"},{"key":"BF1704717_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1046\/j.1365-2141.2000.02196.x","volume":"111","author":"R Champlin","year":"2000","unstructured":"Champlin R, Khouri I, Shimoni A et al. Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy. Br J Haematol 2000; 111: 18\u201329.","journal-title":"Br J Haematol"},{"key":"BF1704717_CR9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1046\/j.1365-2141.2001.03150.x","volume":"115","author":"R Pawson","year":"2001","unstructured":"Pawson R, Potter MN, Theocharous P et al. Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG+\/\u2212 Ida) and second allogeneic stem cell transplant. Br J Haematol 2001; 115: 622\u2013629.","journal-title":"Br J Haematol"},{"key":"BF1704717_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/sj.bmt.1701627","volume":"23","author":"EP Alessandrino","year":"1999","unstructured":"Alessandrino EP, Bernasconi P, Caldera D et al. Chemotherapy and donor peripheral blood progenitor cells for acute leukemia in early relapse after allogeneic bone marrow transplantation. Bone Marrow Transplant 1999; 23: 607\u2013612.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704717_CR11","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1182\/blood-2002-05-1340","volume":"101","author":"D Niederwieser","year":"2003","unstructured":"Niederwieser D, Maris M, Shizuru JA et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 2003; 101: 1620\u20131629.","journal-title":"Blood"},{"key":"BF1704717_CR12","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1046\/j.1365-2141.2000.02123.x","volume":"109","author":"AM Raiola","year":"2000","unstructured":"Raiola AM, Van Lint MT, Lamparelli T et al. Reduced intensity thiotepa\u2013cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age. Br J Haematol 2000; 109: 716\u2013721.","journal-title":"Br J Haematol"},{"key":"BF1704717_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1182\/blood.V97.3.631","volume":"97","author":"S Giralt","year":"2001","unstructured":"Giralt S, Thall PF, Khouri I et al. Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood 2001; 97: 631\u2013637.","journal-title":"Blood"},{"key":"BF1704717_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1182\/blood.V99.1.75","volume":"99","author":"P Corradini","year":"2002","unstructured":"Corradini P, Tarella C, Olivieri A et al. Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies. Blood 2002; 99: 75\u201382.","journal-title":"Blood"},{"key":"BF1704717_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s002770100344","volume":"80","author":"EP Alessandrino","year":"2001","unstructured":"Alessandrino EP, Bernasconi P, Colombo AA et al. Thiotepa and fludarabine (TT\u2013FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant. Ann Hematol 2001; 80: 521\u2013524.","journal-title":"Ann Hematol"},{"key":"BF1704717_CR16","first-page":"2","volume":"17","author":"SN Wolff","year":"1990","unstructured":"Wolff SN, Herzig RH, Fay JW et al. High-dose N,N\u2032,N\u2033-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies. Semin Oncol 1990; 17: 2\u20136.","journal-title":"Semin Oncol"},{"key":"BF1704717_CR17","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S1083-8791(99)70008-X","volume":"5","author":"A Alidina","year":"1999","unstructured":"Alidina A, Lawrence D, Ford LA et al. Thiotepa-associated cardiomyopathy during blood or marrow transplantation: association with the female sex and cardiac risk factors. Biol Blood Marrow Transplant 1999; 5: 322\u2013327.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1704717_CR18","first-page":"1989","volume":"11","author":"P Bernasconi","year":"1997","unstructured":"Bernasconi P, Cavigliano PM, Genini E et al. Assessment of chimerism in sex-mismatched allogeneic bone marrrow transplants (allo-BMT) by in situ hybridization and cytogenetics. Is host cell percentage predictive of relapse? Leukemia 1997; 11: 1989\u20131990.","journal-title":"Leukemia"},{"key":"BF1704717_CR19","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","volume":"6","author":"SI Bearman","year":"1988","unstructured":"Bearman SI, Appelbaum FR, Buckner CD et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562\u20131568.","journal-title":"J Clin Oncol"},{"key":"BF1704717_CR20","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus Conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704717_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204\u2013217.","journal-title":"Am J Med"},{"key":"BF1704717_CR22","first-page":"555","volume":"88","author":"R Martino","year":"2003","unstructured":"Martino R, Giralt S, Caballero MD et al. Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study. Haematologica 2003; 88: 555\u2013560.","journal-title":"Haematologica"},{"key":"BF1704717_CR23","first-page":"3702","volume":"95","author":"RE Champlin","year":"2000","unstructured":"Champlin RE, Schmitz N, Horowitz MM et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood 2000; 95: 3702\u20133709.","journal-title":"Blood"},{"key":"BF1704717_CR24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1182\/blood-2002-11-3615","volume":"103","author":"J Casper","year":"2004","unstructured":"Casper J, Knauf W, Kiefer T et al. Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation. Blood 2004; 103: 725\u2013731.","journal-title":"Blood"},{"key":"BF1704717_CR25","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/sj.bmt.1702392","volume":"25","author":"A Nagler","year":"2000","unstructured":"Nagler A, Slavin S, Varadi G et al. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma. Bone Marrow Transplant 2000; 25: 1021\u20131028.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704717_CR26","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1200\/JCO.1996.14.4.1156","volume":"14","author":"HK Holland","year":"1996","unstructured":"Holland HK, Dix SP, Geller RB et al. Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow\/stem-cell transplantation and comprehensive supportive care. J Clin Oncol 1996; 14: 1156\u20131164.","journal-title":"J Clin Oncol"},{"key":"BF1704717_CR27","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1182\/blood.V97.11.3380","volume":"97","author":"J Storek","year":"2001","unstructured":"Storek J, Dawson MA, Storer B et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001; 97: 3380\u20133389.","journal-title":"Blood"},{"key":"BF1704717_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s002770050246","volume":"74","author":"YZ Jiang","year":"1997","unstructured":"Jiang YZ, Barrett AJ, Goldman JM et al. Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation. Ann Hematol 1997; 74: 1\u20136.","journal-title":"Ann Hematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704717","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704717.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704717.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:08:04Z","timestamp":1648076884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,1]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12,1]]}},"alternative-id":["BF1704717"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704717","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,1]]},"assertion":[{"value":"26 May 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}